Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest ROE (GILD, TLCR, TECH, AMGN)

Below are the top biotechnology stocks on the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Gilead Sciences Inc GILD is 51.77%. GILD’s operating margin for the same period is 53.40%. The trailing-twelve-month return on equity at Talecris Biotherapeutics Holdings Corp TLCR is 41.93%. TLCR’s PEG ratio is 1.01. The trailing-twelve-month return on equity at Techne Corporation TECH is 22.91%. TECH’s operating margin for the same period is 58.10%. The trailing-twelve-month return on equity at Amgen Inc AMGN is 21.05%. AMGN’s PEG ratio is 1.16. Trading Ideas.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Long IdeasMarketsTrading IdeasBiotechnologyBiotechnology IndustryHealth Carehighest ROELife Sciences Tools & ServicesNASDAQ
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!